Add To Watchlist
Share URL
About The Company
CEO
Mr. Geoffrey Straub Martha
Market Cap
107.94 Billion USD
Sector
Healthcare
Website
https://www.medtronic.comLast Update
2/22/2024, 12:00:00 PM
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
Read More
Overview
Value
42
Growth
42
Health
59
Management
41
Analyst Opinion
89
Total
50
All Scores Out Of 100
Best Features
- Has a low level of debt
- Has a history of share buybacks
- Liked by analysts
- Has strong dividend growth
Risk Factors
- Earnings growth has slowed down recently
- Disliked by Twitter users
- Price-to-earnings ratio of 27.2 is higher than the market average (19.6x)
- High preportion of income is paid as dividend
Market Peers
MDT
Key Figures
PE Ratio (TTM)
27.16
Margin Of Safety (DCF)
48.58%
Revenue Growth (5 Year Average)
3.09%
Ratings Consensus
Strong Buy
Share Buybacks
0.54%
Dividend Yeild (TTM)
3.22%
Valuation
Value Score
42
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 124 USD ✔
Current Price: 85.6 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
27.16x
Free Cashflow Yeild
4.34%
PE/Earnings Growth
0.68
Price/Book
2.18x
Growth
Growth Score
42
- ✔ Revenue growth has improved this yeara
- ✔ Free Cashflow growth has improved this year
- ✘ 5 Year Average Revenue growth of 3.09% is lower than the market average (10.97%)
- ✘ 5 Year Average Earnings growth of 11.88% is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of 9.50% is lower than the market average (12.35%)
Revenue Growth
3.09%
Earnings Growth
11.88%
Cashflow Growth
9.50%
Health
Health Score
59
Altman Z Score
2.95
Piostroski Score
8.00
Debt/Equity
0.46x
Current Assets/Liabilities
1.86x
Free Cashflow/Total Debt
0.25x
Debt/Capital
1.05x
Dividend
Secure Dividend Score
47
- ✔ Dividend yeild of 3.22% is more than the market average (1.85%)
- ✘ At risk of being unsafe
- ✔ Dividends have shown growth over the last 5 years
- ✔ Dividend growth has been accelerating recently
- ✘ Long term dividend payout ratio of 68.60% is high and may limit growth
- ✘ Payout ratio (TTM) of 87.07% is higher than the average (40%)
- ✘ Spending a higher percentage of their income on dividends than last 5 years
Dividend Yeild
3.22%
Dividend Growth
8.43%
Payout Ratio (Earnings)
87.07%
Payout Ratio (Cashflow)
74.18%
Management
Management Score
41
- ✔ Has a history of returning value to shareholders through stock buybacks
- ✔ Has returned higher dividends when earnings have risen
- ✔ Return-on-capital-employed of 11.09% is higher than the market average (10%)
- ✘ Has repurchased shares when overvalued
- ✘ Return-on-equity of 9.48% is lower than the market average (15%)
Average Buybacks/Dilution
0.54%
Recent Buybacks/Dilution
-1.09%
5 Year Price Volitility
14.35%
Return On Assets
5.47%
Return On Capital Employed
11.09%
Return On Equity
9.48%
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
89
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Medtronic plc
Currency
USD
Beta
0.723702
Vol Avg
5817201
Ceo
Mr. Geoffrey Straub Martha
Cik
0001613103
Cusip
585055106
Exchange
New York Stock Exchange
Full Time Employees
95000
Industry
Medical Devices
Sector
Healthcare
Ipo Date
1973-05-02
Address
20 On Hatch
City
Dublin
State
Country
IE
Zip
2
Phone
353 1 438 1700
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
28
Twitter Sentiment
0.00
Stocktwits Sentiment
55.00